Despite current controversies and prognostic uncertainties, biomarkers preferred for diagnosing acute myocardial infarction in patients with renal insufficiency are also highly reliable markers in patients with renal dysfunction.[17] High cTnT levels cannot be explained primarily and solely by renal clearance. This evidence concerns the gene TNNT2 and myocardial infarction.